- A TheraJect MAT system is an array of rapidly dissolving micro-needles in a patch moulded
from inert materials generally regarded as safe (GRAS) by the FDA, into which the active
ingredient has been formulated.
- Delivery to the epidermis is minimally invasive, without pain or blood. There is no “sharps”
waste.
- The MATTM system is capable of delivering traditional drugs or even large molecules, i.e.,
proteins, vaccines, genetic materials (DNA and siRNA), etc.
- Current delivery profiles are rapid onset but systems can be designed to provide sustained
release or patterned delivery.
- Sensitive drugs or vaccines are expected to be stable at room temperature in the dry, solid state
and thus systems have utility for third world applications without a “cold chain”.
- Manufacturing conditions are mild and cost competitive thus can address very large existing and
new markets.
- This patented technology is truly enabling for a number of applications and can extend patent
rights or market share for others.
DrugMAT and VaxMAT
